In the CT26 syngeneic tumor model, in which anti-CTLA4 and TU2218 were coadministered, complete regression was common, and a rechallenge assay was conducted to analyze whether immunological memory had been formed in these mice. This evidence concerns the gene CTLA4 and neoplasm.